Medical illustration of the eye emphasizing ocular health

Newsroom

Press releases

FEBRUARY 10, 2026
Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026
Read More
AUGUST 21, 2025
Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients
Read More
AUGUST 5, 2025
Nicox’s Partner Kowa Initiates NCX 470 Phase 3 Clinical Trial in Japan
Read More

Publications

NCX 470 Phase 3 Efficacy and Safety — Poster Presentation
Read More
Mechanisms of Optic Nerve Protection in Glaucoma — Review Article
Read More
Comparative Efficacy of Novel IOP-Lowering Agents in Open-Angle Glaucoma
Read More

Explore Our Products and Pipeline